Identifying and tackling PXE

Article

Pseudoxanthoma elasticum (PXE) is an inherited metabolic disease with many systemic manifestations. Although the skin changes are striking, the eye and cardiovascular lesions can be most devastating to the patient.

What are the symptoms?

Different forms of pattern dystrophy can be seen in patients with PXE, taking the form of fundus pulverulentus, butterfly-shaped dystrophy, reticular dystrophy and solitary vitelliform pattern dystrophy. However, it is not uncommon for a combination of these pathologies to be found in the same patient. Others may show progression from one pattern to another during follow-up.

How easy is it to diagnose?

It's been detected, so how do we treat it?

Once the diagnosis has been made, patients should be advised regarding eye protection for contact sports or physical activity as choroidal haemorrhage may occur following trivial ocular trauma, resulting in subfoveal haemorrhage and subsequent scarring, ultimately leading to vision loss.6,7

Recent Videos
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
At EURETINA 2024, Martin S. Zinkernagel, MD, PhD, on the future of real-world AI use
Related Content
© 2024 MJH Life Sciences

All rights reserved.